Import Alert 25-02: Detention without physical examination of morel mushrooms due to adulteration
As of October 25, 2026, FDA Import Alert 25-02 (Morel Mushrooms Due to Adulteration) lists 1 firm on its red list in 1 country, covering all morel and false morel mushrooms; 0 firms were added and 0 removed in the last 90 days.
Data from FDA public records, last checked . Request a correction
- 1
- firms on the red list
- 1
- country
- 0
- added in the last 90 days
- 0
- removed in the last 90 days
What changed in the last 90 days
Removed from Import Alert 25-02
SupplierRadar has recorded no removals from Import Alert 25-02 in the last 90 days, as of October 25, 2026. A removal is shown at the top of this page, and on the firm's own page, the day it is found.
Added to Import Alert 25-02
No firm was added to Import Alert 25-02 in the last 90 days, as of October 25, 2026.
Firms on Import Alert 25-02, by country
Listings by country
| Country | Red list | Total |
|---|---|---|
| France | 1 | 1 |
France (1)
FDA refusals from France| Firm | List | Products | Date published |
|---|---|---|---|
| Plantin SASPuymeras | Red | Mushroom, Morel, Whole (Button) (Fungi), Raw, Fresh, Refrigerated; Mushroom, Morel, Whole (Button) (Fungi), Commercially |
Refusal charges named on this alert
| Charge code | Meaning | Refusal lines since 2016 |
|---|---|---|
| POISONOUS | Poisonous or deleterious substance | 2,420 |
What the alert covers and why FDA issued it
- Official title
- Detention Without Physical Examination of Morel Mushrooms Due to Adulteration
- Product scope
- All morel and false morel mushrooms (fresh, canned and dried)
- Last published
In the past, shipments of canned and dried morel mushrooms have been detained due to the presence of Gyromitra esculenta. This mushroom species is known to produce monomethylhydrazine (MMH), a substance which causes severe gastrointestinal disturbance and, in some cases, death.
In addition to Gyromitra esculenta, CFSAN has identified another species, Verpa bohemica, which can also cause toxic effects in some individuals.
Listing on an import alert is FDA's notice to the firm and a fact an importer must consider in its supplier evaluation under 21 CFR 1.505. What the red, green and yellow lists mean.
Questions about Import Alert 25-02
- What is Import Alert 25-02?
- Import Alert 25-02, “Detention without physical examination of morel mushrooms due to adulteration”, is an FDA import alert. FDA may detain all morel and false morel mushrooms from the firms on its red list without physical examination; FDA last published the alert on March 5, 2026.
- Which firms are on Import Alert 25-02?
- As of October 25, 2026, 1 firm is listed on Import Alert 25-02 in 1 country; the most listings are in France (1). The full table, grouped by country, is below on this page and every firm links to its record.
- How do firms get off Import Alert 25-02?
- A firm asks FDA to remove it by submitting evidence that the cause of the listing has been corrected. The Guidance section of the alert on FDA's website gives the procedure and the contact for 25-02; our guide explains the steps and the evidence FDA usually asks for.
- What charge does FDA use under Import Alert 25-02?
- The charge section of Import Alert 25-02 names POISONOUS (poisonous or deleterious substance). Each code is a refusal charge in FDA's reference table; the linked pages give FDA's official statement and refusal counts.
- Which firms were added to Import Alert 25-02 recently?
- No firm was added to Import Alert 25-02 in the last 90 days, as of October 25, 2026.
- Which firms were removed from Import Alert 25-02 recently?
- SupplierRadar has recorded no removals from Import Alert 25-02 in the last 90 days, as of October 25, 2026. A removal is shown at the top of this page and on the firm's page the day it is found.
Built for the person who signs the FSVP file
Look before you order.
Check up to five suppliers against every FDA record in one paste, no account needed. Watch the ones you buy from and get the source the day a record changes.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.